Skip to Navigation

Panelist: A. James Moser, MD, FACS
Share This:

A. James Moser, MD, FACS

Episodes in which A. James Moser, MD, FACS appears

Co-Director, Pancreas and Liver Institute
[email protected]

A. James Moser, M.D., F.A.C.S., is co-director of the Pancreas and Liver Institute at Beth Israel Deaconess Medical Center (BIDMC) and associate professor of surgery at Harvard Medical School.

Dr. Moser graduated from Princeton University and received his medical degree from Washington University School of Medicine in St. Louis, MO.  He completed a general surgery residency and a research fellowship in membrane biology at the UCLA Center for Health Sciences and UCLA School of Medicine in Los Angeles, CA.  Dr. Moser was co-director of the Pancreatic Cancer Center at the University of Pittsburgh Medical Center and pioneered the application of robotic technology to complex pancreatic diseases to reduce the pain of surgery and stress of treatment.  

Dr. Moser is a leader in complex, advanced surgical oncology including vascular resection, minimally-invasive surgery, and pancreatic auto-islet transplantation.  He was recruited to BIDMC in 2012 as the inaugural executive director of the Institute for Hepatobiliary and Pancreatic Surgery.  He is now co-director of the multidisciplinary Pancreas and Liver Institute with Simon Robson, M.D., chief of gastroenterology and hepatology.  The Pancreas and Liver Institute combines BIDMC’s key strengths in advanced endoscopy with advanced minimally-invasive and robotic surgery, integrated patient-centered multidisciplinary care for pancreas and liver diseases, and leadership of innovative clinical trials within the Dana-Farber/Harvard Cancer Center.  He also directs BIDMC’s Pancreatic Cancer Center and is co-director of the weekly Harvard CME-approved HepatoPancreaticoBiliary multidisciplinary conference.

Dr. Moser has been principal investigator of a grant funded by the National Institutes of Health and has received funding for three investigator-initiated clinical trials for pancreatic cancer.  He is currently co-principal investigator for Project Survival™, a joint venture between BIDMC, the Cancer Research and Biostatistics/Pancreatic Cancer Research Team, and Berg Pharma to develop early prognostic and therapeutic biomarkers for pancreatic cancer, a large research collaborative effort.  His current research group includes eight research fellows, including a Fulbright scholar and three students who are pursuing their master’s degrees at the Harvard School of Public Health.  The team is supported by a large community of grateful patients and families who are funding patient-centered care for pancreatic cancer through the Alliance of Families Fighting Pancreatic Cancer.  

Dr. Moser has been published more than 100 times and is an active participant in multiple national and international societies including the Society of Surgical Oncology, American Hepato-Pancreato-Biliary Association, and the Society of American Gastrointestinal and Endoscopic Surgeons. 

Have a comment?

If you'd like to send a comment to the producers of the show, please use our contact form, or feel free to post a comment on the wall of our Facebook Page.